The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.
As a former ballet dancer and now arthritis sufferer, I'm used to dealing with chronic pain. Now that I'm over 50 the aches and pains are more pronounced, but I've learned there are things I eat that ...
In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and publishe ...
For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.
Dalhousie’s Dr. Christine Chambers and her colleagues at Solutions for Kids in Pain (SKIP) are working with hospitals to ...